Thursday, June 20, 2024 7:56:48 AM
Wayne specifically mentioned "Performance enhancing drugs, food safety, human diagnostics are all additional sectors of the market that could be addressed" and stated that the market potential beyond drug testing is enormous. I have to look back into who Sandia has licensed the SpinDx technology in addition to Lifeloc and for what purposes.
Wayne seemed to have a firm grasp on competitors in the industry. He did mention that the current Draeger device is the closest competitive device on the market. I agree and think it would be great to see some type of collaboration with the big boys in this industry.
There was talk about an equity investment in the $5-$10 range and management seemed to at least be open to that idea. A current investor really wanted to get involved to help "speed things up" with an investment from a group he seemed to be well connected with. I have no idea if that ever leads to anything tangible but it certainly sounded like there are other interested parties looking to make a sizeable investment now that they know the SpinDx technology has proven itself. Obviously market acceptance is an unknown but Wayne assured everyone at the meeting that there is no longer any research that needs to be discovered but they still need molds and design finalization.
That's a win as far as I'm concerned!
Recent LCTC News
- Form SD - Specialized disclosure report • Edgar (US Regulatory) • 05/31/2024 07:22:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/23/2024 09:30:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/15/2024 08:30:12 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2024 08:15:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/19/2023 10:14:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/08/2023 09:46:57 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/08/2023 02:57:07 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 10/23/2023 02:57:31 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/19/2023 09:11:04 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2023 09:26:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/07/2023 08:21:40 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM